share_log

Merck & Co | 8-A12B: Registration of a class of securities on a national securities exchange

Merck & Co | 8-A12B: Registration of a class of securities on a national securities exchange

默沙東 | 8-A12B：證券登記/上市
美股SEC公告 ·  05/30 16:35

Moomoo AI 已提取核心訊息

Merck & Co., Inc., a pharmaceutical giant based in New Jersey, and its wholly-owned subsidiary MSD Netherlands Capital B.V., headquartered in the Netherlands, have registered a series of debt securities with the U.S. Securities and Exchange Commission (SEC). The securities include 3.250% Notes due 2032, 3.500% Notes due 2037, 3.700% Notes due 2044, and 3.750% Notes due 2054, all to be listed on the New York Stock Exchange. These debt securities are fully and unconditionally guaranteed by Merck & Co. The registration was completed on May 30, 2024, as part of the company's compliance with the Securities Exchange Act of 1934. The registration references detailed descriptions of the debt securities from the Prospectus dated May 14, 2024, and the Prospectus Supplement dated May 16, 2024. The exhibits filed with the SEC include the Indenture and Officer’s Certificates for each series of notes, confirming the formalization of the securities' terms.
Merck & Co., Inc., a pharmaceutical giant based in New Jersey, and its wholly-owned subsidiary MSD Netherlands Capital B.V., headquartered in the Netherlands, have registered a series of debt securities with the U.S. Securities and Exchange Commission (SEC). The securities include 3.250% Notes due 2032, 3.500% Notes due 2037, 3.700% Notes due 2044, and 3.750% Notes due 2054, all to be listed on the New York Stock Exchange. These debt securities are fully and unconditionally guaranteed by Merck & Co. The registration was completed on May 30, 2024, as part of the company's compliance with the Securities Exchange Act of 1934. The registration references detailed descriptions of the debt securities from the Prospectus dated May 14, 2024, and the Prospectus Supplement dated May 16, 2024. The exhibits filed with the SEC include the Indenture and Officer’s Certificates for each series of notes, confirming the formalization of the securities' terms.
總部位於新澤西州的製藥巨頭默沙東公司及其總部位於荷蘭的全資子公司默沙東荷蘭資本有限公司已向美國證券交易委員會（SEC）註冊了一系列債務證券。這些證券包括2032年到期的3.250％的票據、2037年到期的3.500％的票據、2044年到期的3.700％的票據和2054年到期的3.750％的票據，全部將在紐約證券交易所上市。這些債務證券由默沙東公司全額無條件擔保。作爲公司遵守1934年《證券交易法》的一部分，註冊於2024年5月30日完成。註冊參考文件對2024年5月14日的招股說明書和2024年5月16日的招股說明書補充文件中債務證券的詳細描述。向美國證券交易委員會提交的證物包括每系列票據的契約和高級管理人員證書，以確認證券條款的正式化。
總部位於新澤西州的製藥巨頭默沙東公司及其總部位於荷蘭的全資子公司默沙東荷蘭資本有限公司已向美國證券交易委員會（SEC）註冊了一系列債務證券。這些證券包括2032年到期的3.250％的票據、2037年到期的3.500％的票據、2044年到期的3.700％的票據和2054年到期的3.750％的票據，全部將在紐約證券交易所上市。這些債務證券由默沙東公司全額無條件擔保。作爲公司遵守1934年《證券交易法》的一部分，註冊於2024年5月30日完成。註冊參考文件對2024年5月14日的招股說明書和2024年5月16日的招股說明書補充文件中債務證券的詳細描述。向美國證券交易委員會提交的證物包括每系列票據的契約和高級管理人員證書，以確認證券條款的正式化。
有用
沒用

該公告為獨立文件：

獨立文件1

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間